| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | -8.74% | -0.57% | -8.17% | -7.62% | — |
| 14d | 6 | +66.67% | -4.44% | -1.29% | -3.15% | -2.15% | — |
| 30d | 6 | +83.33% | -12.83% | -1.80% | -11.02% | -14.98% | — |
| 60d | 6 | +83.33% | -14.15% | +0.81% | -14.96% | -21.43% | — |
| 90d | 6 | +83.33% | -7.44% | +3.03% | -10.46% | -18.92% | — |
| 180d | 6 | +83.33% | -33.17% | +6.31% | -42.59% | -70.50% | — |
| 1y | 6(1 pending) | +80.00% | -20.56% | +17.16% | -37.73% | -69.36% | — |
| 2y | 6(5 pending) | +0.00% | +48.79% | +52.88% | -4.10% | -4.10% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 1,650 | — | — | 23,442 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 5,225 | — | — | 28,667 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 3,413 | $14.25 | $48.6K | 25,254 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 798 | $14.23 | $11.4K | 21,792 | Dec 5, 2025 | Dec 5, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Nov 25, 2025 | Nov 26, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 2,217 | $6.99 | $15.5K | 22,590 | Aug 8, 2025 | Aug 8, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 9,750 | — | — | 27,668 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 2,861 | $5.59 | $16.0K | 24,807 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 866 | $8.06 | $7.0K | 17,918 | Dec 6, 2024 | Dec 10, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 87,000 | — | — | 87,000 | Nov 27, 2024 | Nov 27, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 1,466 | $12.73 | $18.7K | 18,784 | Aug 8, 2024 | Aug 9, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 5,375 | — | — | 80,625 | Jul 15, 2024 | Jul 15, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 5,375 | $17.08 | $91.8K | 21,717 | Jul 15, 2024 | Jul 15, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Chief Medical Officer | 5,375 | $8.99 | $48.3K | 27,092 | Jul 15, 2024 | Jul 15, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 2,271 | $15.04 | $34.2K | 21,717 | Jul 12, 2024 | Jul 15, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 4,299 | $15.07 | $64.8K | 23,988 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 755 | $12.41 | $9.4K | 28,287 | Feb 12, 2024 | Feb 14, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 2,576 | — | — | 29,042 | Feb 12, 2024 | Feb 14, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CMO | 534 | $9.63 | $5.1K | 26,466 | Dec 5, 2023 | Dec 6, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 86,000 | — | — | 86,000 | Nov 22, 2023 | Nov 22, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Medical Officer | 1,467 | $17.23 | $25.3K | 25,533 | Aug 8, 2023 | Aug 9, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,000 | — | — | 27,000 | Nov 23, 2022 | Nov 28, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Nov 23, 2022 | Nov 28, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Aug 8, 2022 | Aug 10, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Aug 8, 2022 | Aug 10, 2022 ↗ | View → |